Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 4 studies | 23% ± 4% | |
| neuron | 3 studies | 29% ± 11% | |
| endothelial cell | 3 studies | 17% ± 1% | |
| epithelial cell | 3 studies | 37% ± 9% | |
| ciliated cell | 3 studies | 26% ± 7% | |
| GABAergic neuron | 3 studies | 38% ± 3% | |
| glutamatergic neuron | 3 studies | 47% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 34% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 3611.39 | 2642 / 2642 | 100% | 60.22 | 705 / 705 |
| stomach | 100% | 1864.25 | 359 / 359 | 100% | 34.18 | 286 / 286 |
| esophagus | 100% | 2136.59 | 1444 / 1445 | 100% | 28.98 | 183 / 183 |
| breast | 100% | 1703.32 | 459 / 459 | 100% | 53.45 | 1116 / 1118 |
| intestine | 100% | 2242.15 | 966 / 966 | 100% | 37.22 | 526 / 527 |
| prostate | 100% | 2304.24 | 244 / 245 | 100% | 64.39 | 502 / 502 |
| ovary | 100% | 1421.63 | 180 / 180 | 100% | 27.08 | 428 / 430 |
| lung | 99% | 1728.62 | 574 / 578 | 100% | 37.57 | 1154 / 1155 |
| bladder | 100% | 2127.38 | 21 / 21 | 99% | 30.47 | 500 / 504 |
| uterus | 100% | 1674.75 | 170 / 170 | 99% | 30.99 | 455 / 459 |
| thymus | 100% | 1474.00 | 651 / 653 | 99% | 38.90 | 601 / 605 |
| kidney | 100% | 1724.04 | 89 / 89 | 98% | 31.74 | 883 / 901 |
| pancreas | 99% | 1082.77 | 325 / 328 | 99% | 30.02 | 176 / 178 |
| liver | 100% | 1128.72 | 225 / 226 | 98% | 23.65 | 398 / 406 |
| adrenal gland | 100% | 2430.33 | 258 / 258 | 97% | 32.35 | 224 / 230 |
| skin | 100% | 1684.46 | 1805 / 1809 | 92% | 25.08 | 436 / 472 |
| blood vessel | 100% | 2350.38 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 6093.36 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 946.02 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 26.56 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 11.52 | 1 / 1 |
| adipose | 100% | 1495.40 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 17.46 | 28 / 29 |
| heart | 94% | 1589.95 | 810 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 83% | 18.51 | 66 / 80 |
| peripheral blood | 66% | 666.88 | 610 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0000166 | Molecular function | nucleotide binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0043530 | Molecular function | adenosine 5'-monophosphoramidase activity |
| Gene name | HINT3 |
| Protein name | Adenosine 5'-monophosphoramidase HINT3 (EC 3.9.1.-) (Histidine triad nucleotide-binding protein 3) (HINT-3) |
| Synonyms | |
| Description | FUNCTION: Exhibits adenosine 5'-monophosphoramidase activity, hydrolyzing purine nucleotide phosphoramidates with a single phosphate group such as adenosine 5'monophosphoramidate (AMP-NH2) to yield AMP and NH2 . Hydrolyzes lysyl-AMP (AMP-N-epsilon-(N-alpha-acetyl lysine methyl ester)) generated by lysine tRNA ligase . Hydrolyzes 3-indolepropionic acyl-adenylate and fluorogenic purine nucleoside tryptamine phosphoramidates in vitro . . |
| Accessions | ENST00000229633.7 Q9NQE9 |
